It’s persistent. It’s debilitating. It can make the most trivial activities- walking the dog, playing with the kids or driving to work -unbearable. We made it our mission to change that.
Disc degeneration is one of the leading causes of back pain, affecting 4 of 5 adults throughout life
While many approaches treat the symptoms, Discure treats the problem.
Discure’s mission is to effectively address back pain and restore function, so you can get back to doing the things you love
Discure’s minimally invasive, implantable device is designed to treat and reverse degenerative disc disease, without need for hospitalization or rehab. By restoring the disc’s healthy fluid dynamics, Discure aims to restore cushioning and stability to the spine, revive disc cells, and accelerate tissue healing, to reduce pain and restore function
Granted the Orthopedics This Week award for “Best New Technology in Spine-Care” by a panel of KOL orthopedic surgeons and neuro-surgeons
Top ranked in MedTech Innovator’s startup competition in Dublin, Ireland. Discure is amongst 25 startups accepted to the 2022 MedTech Innovator cohort out of >1000 applicants
Granted FDA Breakthrough Device designation, enabling streamlined review and faster market access for high-impact medical solutions
Published in the prestigious Spine Journal (link to study), highlighting the company’s contributions to leading research in spinal health
Discure is a two-time finalist in the European HealthTech Investment Committee’s startup competition, standing out among hundreds of MedTech and Digital Health companies globally
Awarded 1st Place in the PitchForce Life-Science startup competition, judged by a panel of esteemed life-science investors
61 Jabotinsky St.
BSR Towers, building ‘C’ 4959220
Petach-Tikva, ISRAEL
